US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

EyePoint

12.59

-0.2400-1.87%

Post-market: 12.590.00000.00%16:10 EDT

Volume:813.52K

Turnover:10.16M

Market Cap:1.05B

PE:-3.97

High:12.83

Open:12.69

Low:12.07

Close:12.83

52wk High:19.11

52wk Low:3.91

Shares:83.43M

Float Shares:59.91M

Volume Ratio:0.84

T/O Rate:1.36%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.1700

EPS(LYR):-3.1667

ROE:-72.19%

ROA:-38.89%

PB:3.43

PE(LYR):-3.98

Loading ...

Overview Company News Filings

The Year-End 2025 Biotech Rally And What It Means For 2026

Benzinga_recent_news

EyePoint (EYPT) Valuation Check as Upgraded Earnings Estimates Fuel Strong Share Price Momentum

Simply Wall St.

BRIEF-Eyepoint Reports Inducement Grants Under NASDAQ Listing Rule

EyePoint Grants Stock Options to New Employees as Inducement Awards

EyePoint Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

After Leaping 38% EyePoint, Inc. (NASDAQ:EYPT) Shares Are Not Flying Under The Radar

Simply Wall St.

Cormorant Asset Management Reports Sale of EyePoint Pharmaceuticals Common Shares

EyePoint Pharmaceuticals Inc - Changes Name to EyePoint, Inc. - SEC Filing

THOMSON REUTERS

EyePoint Pharmaceuticals Amends Bylaws to Reflect Name Change

EyePoint Pharmaceuticals Director Nancy Lurker Reports Disposal of Common Shares

Director Nancy Lurker Reports Sale of EyePoint Pharmaceuticals Inc. Common Shares

EyePoint Pharmaceuticals (EYPT) Is Up 8.4% After Positive Phase 3 Safety Review for DURAVYU

Simply Wall St.

EyePoint Pharmaceuticals Receives Positive Phase 3 Trial Update

BRIEF-EyePoint announces positive recommendation by Data Safety Monitoring Committee for phase 3 trials for Duravyu

EyePoint Pharmaceuticals Inc - Topline Data for Lugano Expected Mid-2026

THOMSON REUTERS

EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration

A Look at EyePoint Pharmaceuticals’s (EYPT) Valuation Following Steep Revenue Drop and Wider Quarterly Losses

Simply Wall St.

EyePoint reports inducement grants under NASDAQ listing rule

EyePoint Pharmaceuticals Grants Stock Options to New Employees

Promising Outlook for EyePoint Pharmaceuticals with Duravyu’s Potential Impact on Wet AMD Treatment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EYPT/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EYPT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EYPT\",,,,,undefined,":{"symbol":"EYPT","market":"US","secType":"STK","nameCN":"EyePoint","latestPrice":12.59,"timestamp":1774382400000,"preClose":12.83,"halted":0,"volume":813524,"hourTrading":{"tag":"盘后","latestPrice":12.59,"preClose":12.59,"latestTime":"16:10 EDT","volume":21598,"amount":271918.82,"timestamp":1774383004504,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.01870615744349183,"floatShares":59905600,"shares":83431950,"eps":-3.17,"marketStatus":"Post-Mkt","change":-0.24,"latestTime":"03-24 16:17:41 EDT","open":12.69,"high":12.83,"low":12.07,"amount":10164210.398196,"amplitude":0.059236,"askPrice":15,"askSize":300,"bidPrice":12,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-3.17,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774396800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":12.83,"preHourTrading":{"tag":"盘前","latestPrice":12.7,"preClose":12.83,"latestTime":"09:29 EDT","volume":4470,"amount":57455.10477,"timestamp":1774358969089,"change":-0.13,"changeRate":-0.010133,"amplitude":0.06781},"postHourTrading":{"tag":"盘后","latestPrice":12.59,"preClose":12.59,"latestTime":"16:10 EDT","volume":21598,"amount":271918.82,"timestamp":1774383004504,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.837128,"impliedVol":0.7882,"impliedVolPercentile":0.5538},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EYPT\",,,,,undefined,":{"symbol":"EYPT","floatShares":59905600,"roa":"-38.89%","roe":"-72.19%","lyrEps":-3.166673,"volumeRatio":0.837128,"shares":83431950,"dividePrice":0,"high":12.83,"amplitude":0.059236,"preClose":12.83,"low":12.07,"week52Low":3.91,"pbRate":"3.43","psRate":"33.48","week52High":19.11,"institutionHeld":0.5815,"latestPrice":12.59,"committee":-0.967213,"eps":-3.17,"divideRate":0,"volume":813524,"delay":0,"ttmEps":-3.17,"open":12.69,"prevYearClose":18.27,"prevWeekClose":13.23,"prevMonthClose":17.56,"prevQuarterClose":18.27,"fiveDayClose":13.9,"twentyDayClose":17.05,"sixtyDayClose":18.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EYPT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-04","symbol":"EYPT","fiscalQuarterEnding":"2025/12","expectedEps":-0.78,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1772600400000,"reportTimeType":"pre","actualEps":-0.81},{"market":"US","date":"2025-11-05","symbol":"EYPT","fiscalQuarterEnding":"2025/09","expectedEps":-0.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.85},{"market":"US","date":"2025-08-06","symbol":"EYPT","fiscalQuarterEnding":"2025/06","expectedEps":-0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":-0.85},{"market":"US","date":"2025-05-07","symbol":"EYPT","fiscalQuarterEnding":"2025/03","expectedEps":-0.65,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":-0.65},{"market":"US","date":"2025-03-05","symbol":"EYPT","fiscalQuarterEnding":"2024/12","expectedEps":-0.41,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741150800000,"reportTimeType":"pre","actualEps":-0.64}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EYPT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EYPT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":12,"updateTime":1750392000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EYPT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EYPT","date":"2026-03-23","current":-4.047319,"percent":0.585842,"low":-17.174537,"twenty":-7.13159,"median":-5.212616,"eighty":-2.826121,"high":-0.764844,"avg":-5.488148,"sd":2.988417,"marketCap":1103804698},"quantilePoints":[{"date":"2021-03-26","current":-6.318895,"twenty":-3.431949,"median":-2.45699,"eighty":-1.616992,"marketCap":286839920},{"date":"2021-04-01","current":-6.844414,"twenty":-3.459804,"median":-2.473797,"eighty":-1.642233,"marketCap":310695344},{"date":"2021-04-09","current":-6.33789,"twenty":-3.476049,"median":-2.49355,"eighty":-1.660834,"marketCap":287702164},{"date":"2021-04-16","current":-5.93267,"twenty":-3.509728,"median":-2.517525,"eighty":-1.676541,"marketCap":269307620},{"date":"2021-04-23","current":-6.173269,"twenty":-3.546897,"median":-2.53573,"eighty":-1.693188,"marketCap":280229381},{"date":"2021-04-30","current":-6.768436,"twenty":-3.561832,"median":-2.550655,"eighty":-1.703972,"marketCap":307246367},{"date":"2021-05-07","current":-6.290831,"twenty":-3.585661,"median":-2.577992,"eighty":-1.725619,"marketCap":279941966},{"date":"2021-05-14","current":-5.728919,"twenty":-3.617777,"median":-2.601703,"eighty":-1.736213,"marketCap":254936883},{"date":"2021-05-21","current":-6.038939,"twenty":-3.688868,"median":-2.606167,"eighty":-1.747012,"marketCap":268732791},{"date":"2021-05-28","current":-6.34896,"twenty":-3.758867,"median":-2.625354,"eighty":-1.757896,"marketCap":282528699},{"date":"2021-06-04","current":-5.916223,"twenty":-3.833087,"median":-2.633765,"eighty":-1.757896,"marketCap":263271911},{"date":"2021-06-11","current":-6.13582,"twenty":-3.971601,"median":-2.648063,"eighty":-1.769753,"marketCap":273044012},{"date":"2021-06-18","current":-6.168114,"twenty":-4.031446,"median":-2.667311,"eighty":-1.776996,"marketCap":274481086},{"date":"2021-06-25","current":-6.148738,"twenty":-4.076439,"median":-2.672658,"eighty":-1.784872,"marketCap":273618842},{"date":"2021-07-02","current":-5.696625,"twenty":-4.139513,"median":-2.68536,"eighty":-1.794961,"marketCap":253499809},{"date":"2021-07-09","current":-5.199301,"twenty":-4.174872,"median":-2.694091,"eighty":-1.80403,"marketCap":231368873},{"date":"2021-07-16","current":-4.960326,"twenty":-4.238237,"median":-2.704008,"eighty":-1.826995,"marketCap":220734528},{"date":"2021-07-23","current":-5.322017,"twenty":-4.294025,"median":-2.711822,"eighty":-1.843597,"marketCap":236829754},{"date":"2021-07-30","current":-5.309099,"twenty":-4.346909,"median":-2.719962,"eighty":-1.858853,"marketCap":236254924},{"date":"2021-08-06","current":-6.37565,"twenty":-4.370091,"median":-2.731788,"eighty":-1.874633,"marketCap":264972003},{"date":"2021-08-13","current":-7.164818,"twenty":-4.402389,"median":-2.736518,"eighty":-1.891961,"marketCap":297769841},{"date":"2021-08-20","current":-7.06098,"twenty":-4.441277,"median":-2.741305,"eighty":-1.914408,"marketCap":293454336},{"date":"2021-08-27","current":-6.964065,"twenty":-4.472799,"median":-2.743614,"eighty":-1.930259,"marketCap":289426531},{"date":"2021-09-03","current":-7.628628,"twenty":-4.546098,"median":-2.75544,"eighty":-1.941719,"marketCap":317045763},{"date":"2021-09-10","current":-7.102515,"twenty":-4.61979,"median":-2.759953,"eighty":-1.956547,"marketCap":295180538},{"date":"2021-09-17","current":-7.642473,"twenty":-4.694611,"median":-2.760901,"eighty":-1.971028,"marketCap":317621164},{"date":"2021-09-24","current":-8.113205,"twenty":-4.731269,"median":-2.77201,"eighty":-1.988007,"marketCap":337184786},{"date":"2021-10-01","current":-7.760156,"twenty":-4.841039,"median":-2.78384,"eighty":-1.998647,"marketCap":322512069},{"date":"2021-10-08","current":-7.137128,"twenty":-4.919907,"median":-2.790917,"eighty":-2.015619,"marketCap":296619040},{"date":"2021-10-15","current":-7.919374,"twenty":-4.938321,"median":-2.79725,"eighty":-2.019761,"marketCap":329129177},{"date":"2021-10-22","current":-8.313958,"twenty":-4.971427,"median":-2.804116,"eighty":-2.02816,"marketCap":345528096},{"date":"2021-10-29","current":-7.940141,"twenty":-5.098544,"median":-2.833605,"eighty":-2.028584,"marketCap":329992278},{"date":"2021-11-05","current":-7.455146,"twenty":-5.185586,"median":-2.834547,"eighty":-2.038548,"marketCap":405962535},{"date":"2021-11-12","current":-7.40231,"twenty":-5.288363,"median":-2.838221,"eighty":-2.041297,"marketCap":403085408},{"date":"2021-11-19","current":-10.730609,"twenty":-5.348044,"median":-2.838221,"eighty":-2.041297,"marketCap":584324577},{"date":"2021-11-26","current":-10.288687,"twenty":-5.475735,"median":-2.838221,"eighty":-2.041297,"marketCap":560260166},{"date":"2021-12-03","current":-9.043837,"twenty":-5.543465,"median":-2.838221,"eighty":-2.041297,"marketCap":492473092},{"date":"2021-12-10","current":-9.050061,"twenty":-5.631762,"median":-2.838221,"eighty":-2.041297,"marketCap":492812027},{"date":"2021-12-17","current":-8.502327,"twenty":-5.718585,"median":-2.850463,"eighty":-2.041297,"marketCap":462985715},{"date":"2021-12-23","current":-8.43386,"twenty":-5.736973,"median":-2.850463,"eighty":-2.041297,"marketCap":459257426},{"date":"2021-12-31","current":-7.618483,"twenty":-5.783171,"median":-2.850463,"eighty":-2.041297,"marketCap":414856892},{"date":"2022-01-07","current":-8.782418,"twenty":-5.864553,"median":-2.850463,"eighty":-2.041984,"marketCap":478237807},{"date":"2022-01-14","current":-6.180681,"twenty":-5.916223,"median":-2.850463,"eighty":-2.041984,"marketCap":336562822},{"date":"2022-01-21","current":-5.439995,"twenty":-5.918806,"median":-2.850463,"eighty":-2.041984,"marketCap":296229513},{"date":"2022-01-28","current":-5.40265,"twenty":-5.918806,"median":-2.850463,"eighty":-2.041984,"marketCap":294195901},{"date":"2022-02-04","current":-5.813451,"twenty":-5.931903,"median":-2.850463,"eighty":-2.041984,"marketCap":316565635},{"date":"2022-02-11","current":-6.224251,"twenty":-5.976705,"median":-2.850463,"eighty":-2.041984,"marketCap":338935370},{"date":"2022-02-18","current":-5.639172,"twenty":-6.042095,"median":-2.850463,"eighty":-2.041984,"marketCap":307075445},{"date":"2022-02-25","current":-5.801002,"twenty":-6.042095,"median":-2.850463,"eighty":-2.041984,"marketCap":315887764},{"date":"2022-03-04","current":-6.637487,"twenty":-6.076834,"median":-2.850463,"eighty":-2.041984,"marketCap":387742063},{"date":"2022-03-11","current":-7.652837,"twenty":-6.099766,"median":-2.850463,"eighty":-2.041984,"marketCap":447055753},{"date":"2022-03-18","current":-7.447927,"twenty":-6.135388,"median":-2.850467,"eighty":-2.041984,"marketCap":435085578},{"date":"2022-03-25","current":-7.401305,"twenty":-6.148738,"median":-2.850472,"eighty":-2.041984,"marketCap":432362038},{"date":"2022-04-01","current":-7.080776,"twenty":-6.15825,"median":-2.850472,"eighty":-2.041984,"marketCap":413637698},{"date":"2022-04-08","current":-6.96422,"twenty":-6.180751,"median":-2.853843,"eighty":-2.041984,"marketCap":406828847},{"date":"2022-04-14","current":-7.395477,"twenty":-6.19313,"median":-2.860806,"eighty":-2.041984,"marketCap":432021595},{"date":"2022-04-22","current":-7.290577,"twenty":-6.210376,"median":-2.860806,"eighty":-2.041984,"marketCap":425893630},{"date":"2022-04-29","current":-6.585969,"twenty":-6.244501,"median":-2.860806,"eighty":-2.041984,"marketCap":384732546},{"date":"2022-05-06","current":-5.646366,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":378944534},{"date":"2022-05-13","current":-5.017301,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":336726095},{"date":"2022-05-20","current":-4.824523,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":323788187},{"date":"2022-05-27","current":-4.915839,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":329916670},{"date":"2022-06-03","current":-4.59116,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":308126508},{"date":"2022-06-10","current":-4.017899,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":269653253},{"date":"2022-06-17","current":-4.007753,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":268972311},{"date":"2022-06-24","current":-3.678001,"twenty":-6.277913,"median":-2.869838,"eighty":-2.041297,"marketCap":246841678},{"date":"2022-07-01","current":-3.931656,"twenty":-6.277913,"median":-2.869838,"eighty":-2.041297,"marketCap":263865242},{"date":"2022-07-08","current":-4.185311,"twenty":-6.277913,"median":-2.869838,"eighty":-2.041297,"marketCap":280888806},{"date":"2022-07-15","current":-5.027447,"twenty":-6.277913,"median":-2.871843,"eighty":-2.041297,"marketCap":337407038},{"date":"2022-07-22","current":-5.428222,"twenty":-6.277913,"median":-2.876614,"eighty":-2.041297,"marketCap":364304269},{"date":"2022-07-29","current":-4.631745,"twenty":-6.277913,"median":-2.897069,"eighty":-2.041297,"marketCap":310850278},{"date":"2022-08-05","current":-4.689345,"twenty":-6.277913,"median":-2.902765,"eighty":-2.041297,"marketCap":358777096},{"date":"2022-08-12","current":-4.947637,"twenty":-6.277913,"median":-2.918529,"eighty":-2.041297,"marketCap":378538797},{"date":"2022-08-19","current":-4.680438,"twenty":-6.277913,"median":-2.955067,"eighty":-2.041297,"marketCap":358095658},{"date":"2022-08-26","current":-4.578012,"twenty":-6.277913,"median":-2.981219,"eighty":-2.041297,"marketCap":350259121},{"date":"2022-09-02","current":-4.123773,"twenty":-6.277913,"median":-3.01561,"eighty":-2.041297,"marketCap":315505784},{"date":"2022-09-09","current":-3.990174,"twenty":-6.277913,"median":-3.047288,"eighty":-2.041297,"marketCap":305284215},{"date":"2022-09-16","current":-3.638389,"twenty":-6.277913,"median":-3.074739,"eighty":-2.041297,"marketCap":278369506},{"date":"2022-09-23","current":-3.206414,"twenty":-6.277913,"median":-3.090207,"eighty":-2.041297,"marketCap":245319516},{"date":"2022-09-30","current":-3.522602,"twenty":-6.277913,"median":-3.110217,"eighty":-2.041297,"marketCap":269510746},{"date":"2022-10-07","current":-2.743265,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":209884474},{"date":"2022-10-14","current":-2.493877,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":190804068},{"date":"2022-10-21","current":-2.596305,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":198640663},{"date":"2022-10-28","current":-2.444891,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":187056130},{"date":"2022-11-04","current":-2.291539,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":179276232},{"date":"2022-11-11","current":-2.017077,"twenty":-6.277913,"median":-3.117347,"eighty":-2.037196,"marketCap":157803984},{"date":"2022-11-18","current":-1.568353,"twenty":-6.277913,"median":-3.117347,"eighty":-2.028584,"marketCap":122698562},{"date":"2022-11-25","current":-1.44637,"twenty":-6.277913,"median":-3.117347,"eighty":-2.028584,"marketCap":113155340},{"date":"2022-12-02","current":-1.476866,"twenty":-6.277913,"median":-3.117347,"eighty":-2.020056,"marketCap":115541146},{"date":"2022-12-09","current":-1.267752,"twenty":-6.277913,"median":-3.117347,"eighty":-2.016865,"marketCap":99181337},{"date":"2022-12-16","current":-1.076065,"twenty":-6.277913,"median":-3.117347,"eighty":-2.005257,"marketCap":84184846},{"date":"2022-12-23","current":-1.259039,"twenty":-6.277913,"median":-3.117347,"eighty":-1.998555,"marketCap":98499679},{"date":"2022-12-30","current":-1.524788,"twenty":-6.277913,"median":-3.117347,"eighty":-1.991624,"marketCap":119290269},{"date":"2023-01-06","current":-1.420231,"twenty":-6.277913,"median":-3.117347,"eighty":-1.975507,"marketCap":111110364},{"date":"2023-01-13","current":-2.195695,"twenty":-6.277913,"median":-3.117347,"eighty":-1.963772,"marketCap":171777987},{"date":"2023-01-20","current":-1.834102,"twenty":-6.277913,"median":-3.117347,"eighty":-1.951722,"marketCap":143489152},{"date":"2023-01-27","current":-2.060642,"twenty":-6.277913,"median":-3.110217,"eighty":-1.94839,"marketCap":161212277},{"date":"2023-02-03","current":-2.021433,"twenty":-6.277913,"median":-3.099225,"eighty":-1.94839,"marketCap":158144813},{"date":"2023-02-10","current":-1.768754,"twenty":-6.277913,"median":-3.099225,"eighty":-1.939746,"marketCap":138376712},{"date":"2023-02-17","current":-1.503005,"twenty":-6.277913,"median":-3.099225,"eighty":-1.928219,"marketCap":117586122},{"date":"2023-02-24","current":-1.428944,"twenty":-6.277913,"median":-3.099225,"eighty":-1.918005,"marketCap":111792023},{"date":"2023-03-03","current":-1.086611,"twenty":-6.277913,"median":-3.099225,"eighty":-1.903097,"marketCap":111110364},{"date":"2023-03-10","current":-0.811808,"twenty":-6.277913,"median":-3.099225,"eighty":-1.876527,"marketCap":83010660},{"date":"2023-03-17","current":-0.788326,"twenty":-6.277913,"median":-3.099225,"eighty":-1.862926,"marketCap":80609526},{"date":"2023-03-24","current":-0.764844,"twenty":-6.277913,"median":-3.099225,"eighty":-1.844212,"marketCap":78208391},{"date":"2023-03-31","current":-0.986247,"twenty":-6.277913,"median":-3.098122,"eighty":-1.833959,"marketCap":100847662},{"date":"2023-04-06","current":-1.014761,"twenty":-6.277913,"median":-3.099225,"eighty":-1.830785,"marketCap":103763326},{"date":"2023-04-14","current":-1.298223,"twenty":-6.277913,"median":-3.096321,"eighty":-1.818062,"marketCap":132748453},{"date":"2023-04-21","current":-1.905402,"twenty":-6.277913,"median":-3.074739,"eighty":-1.806764,"marketCap":194834939},{"date":"2023-04-28","current":-2.101645,"twenty":-6.277913,"median":-3.057645,"eighty":-1.806764,"marketCap":214901566},{"date":"2023-05-05","current":-2.270232,"twenty":-6.25452,"median":-3.0294,"eighty":-1.806764,"marketCap":232567058},{"date":"2023-05-12","current":-2.136295,"twenty":-6.25452,"median":-3.000653,"eighty":-1.806764,"marketCap":218846287},{"date":"2023-05-19","current":-2.052584,"twenty":-6.25452,"median":-2.918529,"eighty":-1.806764,"marketCap":210270806},{"date":"2023-05-26","current":-1.985615,"twenty":-6.25452,"median":-2.89721,"eighty":-1.806764,"marketCap":203410421},{"date":"2023-06-02","current":-1.995661,"twenty":-6.25452,"median":-2.88216,"eighty":-1.806764,"marketCap":204439478},{"date":"2023-06-09","current":-2.035842,"twenty":-6.25452,"median":-2.865856,"eighty":-1.806764,"marketCap":208555710},{"date":"2023-06-16","current":-2.27358,"twenty":-6.25452,"median":-2.836384,"eighty":-1.806764,"marketCap":232910077},{"date":"2023-06-23","current":-2.08272,"twenty":-6.25953,"median":-2.815898,"eighty":-1.806567,"marketCap":213357979},{"date":"2023-06-30","current":-2.752405,"twenty":-6.264539,"median":-2.79725,"eighty":-1.80637,"marketCap":281961831},{"date":"2023-07-07","current":-2.882993,"twenty":-6.219784,"median":-2.79725,"eighty":-1.80637,"marketCap":295339582},{"date":"2023-07-14","current":-3.63304,"twenty":-6.19313,"median":-2.79725,"eighty":-1.80637,"marketCap":372175897},{"date":"2023-07-21","current":-3.95114,"twenty":-6.180681,"median":-2.79725,"eighty":-1.80637,"marketCap":404762726},{"date":"2023-07-28","current":-3.515845,"twenty":-6.158749,"median":-2.79725,"eighty":-1.80637,"marketCap":360170223},{"date":"2023-08-04","current":-4.05643,"twenty":-6.148902,"median":-2.79725,"eighty":-1.8052,"marketCap":429803132},{"date":"2023-08-11","current":-4.629056,"twenty":-6.137112,"median":-2.79725,"eighty":-1.8052,"marketCap":490476296},{"date":"2023-08-18","current":-4.361614,"twenty":-6.101011,"median":-2.79725,"eighty":-1.8052,"marketCap":462139221},{"date":"2023-08-25","current":-3.800317,"twenty":-6.098107,"median":-2.79725,"eighty":-1.8052,"marketCap":402666346},{"date":"2023-09-01","current":-3.272036,"twenty":-6.067271,"median":-2.79725,"eighty":-1.8052,"marketCap":346691876},{"date":"2023-09-08","current":-3.321563,"twenty":-6.026618,"median":-2.79725,"eighty":-1.8052,"marketCap":351939482},{"date":"2023-09-15","current":-3.631927,"twenty":-5.954331,"median":-2.79725,"eighty":-1.8052,"marketCap":384824484},{"date":"2023-09-22","current":-2.756963,"twenty":-5.954331,"median":-2.790917,"eighty":-1.8052,"marketCap":292116767},{"date":"2023-09-29","current":-2.641402,"twenty":-5.954331,"median":-2.778602,"eighty":-1.8052,"marketCap":279872352},{"date":"2023-10-06","current":-2.793282,"twenty":-5.954331,"median":-2.768311,"eighty":-1.8052,"marketCap":295965012},{"date":"2023-10-13","current":-2.674419,"twenty":-5.954331,"median":-2.767265,"eighty":-1.8052,"marketCap":283370756},{"date":"2023-10-20","current":-2.476314,"twenty":-5.954331,"median":-2.759953,"eighty":-1.8052,"marketCap":262380330},{"date":"2023-10-27","current":-2.039467,"twenty":-5.962331,"median":-2.756201,"eighty":-1.801691,"marketCap":216093723},{"date":"2023-11-03","current":-2.570254,"twenty":-5.962331,"median":-2.752288,"eighty":-1.801691,"marketCap":257405759},{"date":"2023-11-10","current":-2.326979,"twenty":-5.962331,"median":-2.743614,"eighty":-1.801691,"marketCap":233042251},{"date":"2023-11-17","current":-2.178898,"twenty":-5.962331,"median":-2.743614,"eighty":-1.801691,"marketCap":218212289},{"date":"2023-11-24","current":-2.164795,"twenty":-5.962331,"median":-2.743614,"eighty":-1.801691,"marketCap":216799912},{"date":"2023-12-01","current":-2.203578,"twenty":-5.962331,"median":-2.74344,"eighty":-1.801691,"marketCap":220683950},{"date":"2023-12-08","current":-9.955568,"twenty":-6.049293,"median":-2.752172,"eighty":-1.802861,"marketCap":997030242},{"date":"2023-12-15","current":-9.574831,"twenty":-6.092369,"median":-2.75544,"eighty":-1.802861,"marketCap":958900191},{"date":"2023-12-22","current":-9.77225,"twenty":-6.109725,"median":-2.759953,"eighty":-1.802861,"marketCap":978671329},{"date":"2023-12-29","current":-11.074277,"twenty":-6.140987,"median":-2.764196,"eighty":-1.806567,"marketCap":1109066691},{"date":"2024-01-05","current":-9.368011,"twenty":-6.14956,"median":-2.778602,"eighty":-1.80637,"marketCap":938187570},{"date":"2024-01-12","current":-9.570131,"twenty":-6.168114,"median":-2.793282,"eighty":-1.80637,"marketCap":958429449},{"date":"2024-01-19","current":-10.745245,"twenty":-6.181032,"median":-2.79725,"eighty":-1.8052,"marketCap":1076114794},{"date":"2024-01-26","current":-11.704138,"twenty":-6.200408,"median":-2.804116,"eighty":-1.80637,"marketCap":1172146036},{"date":"2024-02-02","current":-13.401003,"twenty":-6.254636,"median":-2.834547,"eighty":-1.80637,"marketCap":1342083674},{"date":"2024-02-09","current":-13.687731,"twenty":-6.30708,"median":-2.853195,"eighty":-1.80637,"marketCap":1370798898},{"date":"2024-02-16","current":-13.668929,"twenty":-6.37565,"median":-2.853195,"eighty":-1.80637,"marketCap":1368915933},{"date":"2024-02-23","current":-12.268193,"twenty":-6.417185,"median":-2.853195,"eighty":-1.80637,"marketCap":1228635001},{"date":"2024-03-01","current":-12.789944,"twenty":-6.540499,"median":-2.856467,"eighty":-1.806567,"marketCap":1280887294},{"date":"2024-03-08","current":-16.829528,"twenty":-6.600791,"median":-2.864789,"eighty":-1.806567,"marketCap":1191446432},{"date":"2024-03-15","current":-15.302231,"twenty":-6.677113,"median":-2.871843,"eighty":-1.806567,"marketCap":1083321418},{"date":"2024-03-22","current":-16.48474,"twenty":-6.761591,"median":-2.887382,"eighty":-1.806567,"marketCap":1167037148},{"date":"2024-03-28","current":-14.647627,"twenty":-6.81781,"median":-2.892586,"eighty":-1.806567,"marketCap":1036978781},{"date":"2024-04-05","current":-14.18307,"twenty":-6.857077,"median":-2.918529,"eighty":-1.80637,"marketCap":1004090458},{"date":"2024-04-12","current":-16.111686,"twenty":-6.901762,"median":-3.019122,"eighty":-1.80637,"marketCap":1140626828},{"date":"2024-04-19","current":-12.317803,"twenty":-6.964065,"median":-3.050414,"eighty":-1.807354,"marketCap":872038860},{"date":"2024-04-26","current":-11.374611,"twenty":-6.977129,"median":-3.092915,"eighty":-1.807507,"marketCap":805265598},{"date":"2024-05-03","current":-14.669933,"twenty":-6.99966,"median":-3.108194,"eighty":-1.807507,"marketCap":1038557911},{"date":"2024-05-10","current":-8.362276,"twenty":-7.014797,"median":-3.172728,"eighty":-1.811775,"marketCap":659909031},{"date":"2024-05-17","current":-8.263275,"twenty":-7.045704,"median":-3.193664,"eighty":-1.811775,"marketCap":652096375},{"date":"2024-05-24","current":-7.332667,"twenty":-7.080776,"median":-3.232956,"eighty":-1.817369,"marketCap":578657406},{"date":"2024-05-31","current":-7.095065,"twenty":-7.101547,"median":-3.286694,"eighty":-1.83021,"marketCap":559907031},{"date":"2024-06-07","current":-6.118256,"twenty":-7.101547,"median":-3.330137,"eighty":-1.834973,"marketCap":482822156},{"date":"2024-06-14","current":-6.131456,"twenty":-7.102515,"median":-3.412645,"eighty":-1.845001,"marketCap":483863843},{"date":"2024-06-21","current":-5.385649,"twenty":-7.102515,"median":-3.462472,"eighty":-1.863418,"marketCap":425008500},{"date":"2024-06-28","current":-5.775053,"twenty":-7.102515,"median":-3.473443,"eighty":-1.885785,"marketCap":455738281},{"date":"2024-07-05","current":-5.689252,"twenty":-7.102515,"median":-3.509148,"eighty":-1.903349,"marketCap":448967312},{"date":"2024-07-12","current":-6.54066,"twenty":-7.102515,"median":-3.561832,"eighty":-1.919277,"marketCap":516156156},{"date":"2024-07-15","current":-6.817862,"twenty":-7.102515,"median":-3.561832,"eighty":-1.920686,"marketCap":538031593},{"date":"2024-08-02","current":-6.025855,"twenty":-7.124873,"median":-3.608452,"eighty":-1.963141,"marketCap":475530343},{"date":"2024-08-09","current":-5.503143,"twenty":-7.124873,"median":-3.632484,"eighty":-1.96681,"marketCap":477788393},{"date":"2024-08-16","current":-5.054645,"twenty":-7.124873,"median":-3.645064,"eighty":-1.980482,"marketCap":438849322},{"date":"2024-08-23","current":-5.547781,"twenty":-7.124873,"median":-3.698817,"eighty":-1.980482,"marketCap":481663890},{"date":"2024-08-30","current":-5.375183,"twenty":-7.124873,"median":-3.810182,"eighty":-1.980482,"marketCap":466678791},{"date":"2024-09-06","current":-4.968346,"twenty":-7.124873,"median":-3.83418,"eighty":-1.980482,"marketCap":431356772},{"date":"2024-09-13","current":-5.473811,"twenty":-7.124873,"median":-3.903238,"eighty":-1.980482,"marketCap":475241704},{"date":"2024-09-20","current":-5.658737,"twenty":-7.124873,"median":-3.951544,"eighty":-1.980482,"marketCap":491297167},{"date":"2024-09-27","current":-4.97451,"twenty":-7.124873,"median":-3.986281,"eighty":-1.980482,"marketCap":431891954},{"date":"2024-10-04","current":-5.159436,"twenty":-7.124873,"median":-4.012982,"eighty":-1.980482,"marketCap":447947417},{"date":"2024-10-11","current":-5.079302,"twenty":-7.124873,"median":-4.052753,"eighty":-1.980482,"marketCap":440990050},{"date":"2024-10-18","current":-6.873084,"twenty":-7.124873,"median":-4.083441,"eighty":-1.980482,"marketCap":596728041},{"date":"2024-10-25","current":-5.892976,"twenty":-7.124873,"median":-4.137591,"eighty":-1.980482,"marketCap":511634087},{"date":"2024-10-31","current":-8.74412,"twenty":-7.137898,"median":-4.196959,"eighty":-1.980482,"marketCap":759173235},{"date":"2024-11-08","current":-7.626837,"twenty":-7.20923,"median":-4.361614,"eighty":-1.97961,"marketCap":789911501},{"date":"2024-11-15","current":-7.106109,"twenty":-7.272765,"median":-4.416406,"eighty":-1.97961,"marketCap":735979669},{"date":"2024-11-22","current":-5.656435,"twenty":-7.272765,"median":-4.456923,"eighty":-1.97961,"marketCap":585837010},{"date":"2024-11-29","current":-5.995144,"twenty":-7.272765,"median":-4.545502,"eighty":-1.97961,"marketCap":620917070},{"date":"2024-12-06","current":-5.527726,"twenty":-7.272765,"median":-4.586087,"eighty":-1.97961,"marketCap":572506587},{"date":"2024-12-13","current":-5.378694,"twenty":-7.272765,"median":-4.621598,"eighty":-1.97961,"marketCap":557071360},{"date":"2024-12-20","current":-4.823212,"twenty":-7.272765,"median":-4.654737,"eighty":-1.97961,"marketCap":499540061},{"date":"2024-12-27","current":-5.134824,"twenty":-7.272765,"median":-4.680438,"eighty":-1.97961,"marketCap":531813717},{"date":"2025-01-03","current":-5.439662,"twenty":-7.272765,"median":-4.688488,"eighty":-1.97961,"marketCap":563385771},{"date":"2025-01-10","current":-6.171273,"twenty":-7.274134,"median":-4.721011,"eighty":-1.978739,"marketCap":639158702},{"date":"2025-01-17","current":-4.924825,"twenty":-7.274134,"median":-4.757117,"eighty":-1.978739,"marketCap":510064079},{"date":"2025-01-24","current":-5.974822,"twenty":-7.274134,"median":-4.81202,"eighty":-1.978739,"marketCap":618812267},{"date":"2025-01-31","current":-5.45321,"twenty":-7.274134,"median":-4.825842,"eighty":-1.978739,"marketCap":564788974},{"date":"2025-02-07","current":-4.484503,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":464460001},{"date":"2025-02-14","current":-4.274504,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":442710363},{"date":"2025-02-21","current":-4.301601,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":445516768},{"date":"2025-02-28","current":-4.22031,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":437097553},{"date":"2025-03-07","current":-3.581647,"twenty":-7.275504,"median":-4.857083,"eighty":-1.977868,"marketCap":468730143},{"date":"2025-03-14","current":-3.586899,"twenty":-7.275504,"median":-4.857083,"eighty":-1.977868,"marketCap":469417430},{"date":"2025-03-21","current":-3.203526,"twenty":-7.275504,"median":-4.857083,"eighty":-1.982224,"marketCap":419245436},{"date":"2025-03-28","current":-3.103744,"twenty":-7.275504,"median":-4.857083,"eighty":-1.982224,"marketCap":406186971},{"date":"2025-04-04","current":-2.620589,"twenty":-7.275504,"median":-4.857083,"eighty":-1.986581,"marketCap":342956512},{"date":"2025-04-11","current":-2.520807,"twenty":-7.274134,"median":-4.853805,"eighty":-1.998664,"marketCap":329898048},{"date":"2025-04-17","current":-2.914683,"twenty":-7.274134,"median":-4.853805,"eighty":-2.003697,"marketCap":381444618},{"date":"2025-04-25","current":-3.4346,"twenty":-7.275504,"median":-4.857083,"eighty":-2.020056,"marketCap":449486090},{"date":"2025-05-02","current":-3.744449,"twenty":-7.275504,"median":-4.857083,"eighty":-2.020056,"marketCap":490036058},{"date":"2025-05-09","current":-2.859698,"twenty":-7.275504,"median":-4.857083,"eighty":-2.021433,"marketCap":419749277},{"date":"2025-05-16","current":-2.681567,"twenty":-7.275504,"median":-4.857083,"eighty":-2.025797,"marketCap":393603129},{"date":"2025-05-23","current":-2.625311,"twenty":-7.275504,"median":-4.857083,"eighty":-2.025797,"marketCap":385345721},{"date":"2025-05-30","current":-3.380087,"twenty":-7.275504,"median":-4.857083,"eighty":-2.025797,"marketCap":496132616},{"date":"2025-06-06","current":-3.867645,"twenty":-7.275504,"median":-4.857083,"eighty":-2.029337,"marketCap":567696822},{"date":"2025-06-13","current":-4.153616,"twenty":-7.275504,"median":-4.857083,"eighty":-2.030146,"marketCap":609671980},{"date":"2025-06-20","current":-4.181745,"twenty":-7.275519,"median":-4.85959,"eighty":-2.030146,"marketCap":613800685},{"date":"2025-06-27","current":-4.861513,"twenty":-7.275519,"median":-4.869751,"eighty":-2.049961,"marketCap":713577702},{"date":"2025-07-03","current":-4.556789,"twenty":-7.275519,"median":-4.869751,"eighty":-2.092939,"marketCap":668850073},{"date":"2025-07-11","current":-5.184989,"twenty":-7.275519,"median":-4.878866,"eighty":-2.11162,"marketCap":761057800},{"date":"2025-07-18","current":-4.828696,"twenty":-7.275519,"median":-4.878866,"eighty":-2.147002,"marketCap":708760880},{"date":"2025-07-25","current":-4.917769,"twenty":-7.275519,"median":-4.892425,"eighty":-2.165118,"marketCap":721835110},{"date":"2025-08-01","current":-4.60367,"twenty":-7.275519,"median":-4.894961,"eighty":-2.173127,"marketCap":675731247},{"date":"2025-08-08","current":-3.951022,"twenty":-7.275519,"median":-4.894961,"eighty":-2.187675,"marketCap":692934181},{"date":"2025-08-15","current":-4.264217,"twenty":-7.275519,"median":-4.894961,"eighty":-2.213274,"marketCap":747862561},{"date":"2025-08-22","current":-4.558978,"twenty":-7.275519,"median":-4.894961,"eighty":-2.238916,"marketCap":799558130},{"date":"2025-08-29","current":-4.558978,"twenty":-7.275519,"median":-4.894961,"eighty":-2.269562,"marketCap":799558130},{"date":"2025-09-05","current":-4.669022,"twenty":-7.275534,"median":-4.895546,"eighty":-2.300854,"marketCap":818857809},{"date":"2025-09-12","current":-5.238895,"twenty":-7.275519,"median":-4.91446,"eighty":-2.329404,"marketCap":918802575},{"date":"2025-09-19","current":-5.407891,"twenty":-7.275519,"median":-4.923075,"eighty":-2.352075,"marketCap":948441368},{"date":"2025-09-26","current":-5.183872,"twenty":-7.275519,"median":-4.932745,"eighty":-2.419563,"marketCap":909152735},{"date":"2025-10-03","current":-5.305707,"twenty":-7.275519,"median":-4.942197,"eighty":-2.463236,"marketCap":930520237},{"date":"2025-10-10","current":-5.49239,"twenty":-7.275519,"median":-4.956209,"eighty":-2.494254,"marketCap":963260764},{"date":"2025-10-17","current":-4.539327,"twenty":-7.275519,"median":-4.96602,"eighty":-2.56263,"marketCap":796111758},{"date":"2025-10-24","current":-4.519677,"twenty":-7.275519,"median":-4.96602,"eighty":-2.574573,"marketCap":792665387},{"date":"2025-10-31","current":-5.619401,"twenty":-7.275519,"median":-5.020563,"eighty":-2.612621,"marketCap":985536169},{"date":"2025-11-07","current":-4.346629,"twenty":-7.275519,"median":-5.033717,"eighty":-2.637757,"marketCap":894327662},{"date":"2025-11-14","current":-4.631211,"twenty":-7.275519,"median":-5.033717,"eighty":-2.650995,"marketCap":952880902},{"date":"2025-11-21","current":-5.488246,"twenty":-7.275519,"median":-5.054089,"eighty":-2.672098,"marketCap":1129217680},{"date":"2025-11-28","current":-5.96706,"twenty":-7.275519,"median":-5.068604,"eighty":-2.688416,"marketCap":1227734472},{"date":"2025-12-05","current":-6.727528,"twenty":-7.275519,"median":-5.094712,"eighty":-2.710416,"marketCap":1384202318},{"date":"2025-12-12","current":-6.478062,"twenty":-7.275519,"median":-5.147222,"eighty":-2.740497,"marketCap":1332874242},{"date":"2025-12-19","current":-6.864332,"twenty":-7.275519,"median":-5.165076,"eighty":-2.756051,"marketCap":1412349973},{"date":"2025-12-26","current":-7.347169,"twenty":-7.289324,"median":-5.172773,"eighty":-2.793921,"marketCap":1511694637},{"date":"2026-01-02","current":-7.351192,"twenty":-7.324613,"median":-5.18443,"eighty":-2.826121,"marketCap":1512522509},{"date":"2026-01-09","current":-6.872379,"twenty":-7.324613,"median":-5.207453,"eighty":-2.826121,"marketCap":1414005717},{"date":"2026-01-16","current":-6.373447,"twenty":-7.324613,"median":-5.221197,"eighty":-2.826121,"marketCap":1311349564},{"date":"2026-01-23","current":-6.572618,"twenty":-7.324613,"median":-5.24479,"eighty":-2.826121,"marketCap":1352329238},{"date":"2026-01-30","current":-5.934871,"twenty":-7.324613,"median":-5.267112,"eighty":-2.826121,"marketCap":1221111495},{"date":"2026-02-06","current":-5.122095,"twenty":-7.286659,"median":-5.256581,"eighty":-2.826121,"marketCap":1053881310},{"date":"2026-02-13","current":-5.234757,"twenty":-7.238055,"median":-5.24837,"eighty":-2.826121,"marketCap":1077061732},{"date":"2026-02-20","current":-5.914752,"twenty":-7.198521,"median":-5.24479,"eighty":-2.826121,"marketCap":1216972134},{"date":"2026-02-27","current":-7.186223,"twenty":-7.149753,"median":-5.24479,"eighty":-2.826121,"marketCap":1478579749},{"date":"2026-03-06","current":-5.668547,"twenty":-7.140441,"median":-5.24479,"eighty":-2.826121,"marketCap":1314887532},{"date":"2026-03-13","current":-5.046302,"twenty":-7.140441,"median":-5.24086,"eighty":-2.826121,"marketCap":1170550258},{"date":"2026-03-20","current":-4.959979,"twenty":-7.13159,"median":-5.215152,"eighty":-2.826121,"marketCap":1150526590},{"date":"2026-03-23","current":-4.758558,"twenty":-7.13159,"median":-5.212616,"eighty":-2.826121,"marketCap":1103804698}],"updateTime":1774348851240},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EYPT\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2600708537","title":"The Year-End 2025 Biotech Rally And What It Means For 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2600708537","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600708537?lang=en_us&edition=fundamental","pubTime":"2025-12-31 23:54","pubTimestamp":1767196440,"startTime":"0","endTime":"0","summary":"Biotechnology stocks are wrapping up 2025 on a high note, bouncing back from a rocky start to deliver some of the year’s most impressive gains. What began as a sector weighed down by tariff fears and political noise has transformed into one of the market’s standout performers, powered by deal making, drug approvals, and breakthrough clinical results. The big question heading into 2026 is simple: can this momentum last?The performance metrics speak volumes. The iShares Biotechnology ETF  has climbed 29.51% year to date through December 29, while the State Street SPDR S&P Biotech ETF  has done even better with gains around 35.84%. The Nasdaq Biotechnology Index sits at 5,766.59, marking a 34% jump for the year.Regulatory wins provided another boost. The FDA greenlit 44 new therapies in 2025, with 26 approvals coming in the second half alone. December saw notable wins including Cytokinetics Incorporated’s  Myqorzo for a heart condition, marking the company’s first approval after 27 years ","market":"hk","thumbnail":"/next-assets/images/benzinga-post-card-placeholder.svg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["/next-assets/images/benzinga-post-card-placeholder.svg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/25/12/49650052/the-year-end-2025-biotech-rally-and-what-it-means-for-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/25/12/49650052/the-year-end-2025-biotech-rally-and-what-it-means-for-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0306807586.USD","NVIW.SI","IE00BVYPNW00.USD","LU1935042991.SGD","IBB","EYPT","LU1037948897.HKD","LU0256863811.USD","IE00B1BXHZ80.USD","ITCI","LU2063271972.USD","LU0471298694.HKD","LU0823434740.USD","IE00BBT3K403.USD","IE0005OL40V9.USD","MNPR","USAW.SI","IONS","QID","LU2430703178.SGD","RNA","BK4581","SQQQ","BK4532","MNQmain","CYTK","LU1116320737.USD","SG9999014880.SGD","MRK","PSQ","NVS","LU0432979614.USD","BK4505","GPCR","VRNA","LU2592432038.USD","SG9999014906.USD","TSYW.SI","LU2089984988.USD","IE00BJT1NW94.SGD","JNJ","QLD",".IXIC","USJW.SI","PFE","TQQQ","NQmain","OMER"],"gpt_icon":1},{"id":"2593444068","title":"EyePoint (EYPT) Valuation Check as Upgraded Earnings Estimates Fuel Strong Share Price Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2593444068","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593444068?lang=en_us&edition=fundamental","pubTime":"2025-12-24 04:14","pubTimestamp":1766520889,"startTime":"0","endTime":"0","summary":"EyePoint (EYPT) has been drawing attention after fresh upward revisions to its earnings estimates and strong momentum scores, a combination that often signals shifting expectations for a company’s financial trajectory.\nSee our latest analysis for EyePoint.\nThe latest leg higher, including a 1 day share price return of 8.15 percent and 30 day share price return of 37.79 percent, adds to a powerful year to date share price return of 134.74 percent and a 3 year total shareholder return of 552.25...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eypt/eyepoint/news/eyepoint-eypt-valuation-check-as-upgraded-earnings-estimates","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eypt/eyepoint/news/eyepoint-eypt-valuation-check-as-upgraded-earnings-estimates","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EYPT"],"gpt_icon":0},{"id":"2591989779","title":"BRIEF-Eyepoint Reports Inducement Grants Under NASDAQ Listing Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2591989779","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591989779?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:07","pubTimestamp":1765886868,"startTime":"0","endTime":"0","summary":"BRIEF-Eyepoint Reports Inducement Grants Under NASDAQ Listing Rule Dec 16 (Reuters) - EyePoint Inc EYPT.O:EYEPOINT REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)Source text: ID:nGNX2kgjzGFurther company coverage: EYPT.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA3VSZVZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4588","EYPT","LU0889565916.HKD","BK4007","BK4585","LU0320765992.SGD"],"gpt_icon":0},{"id":"2591598949","title":"EyePoint Grants Stock Options to New Employees as Inducement Awards","url":"https://stock-news.laohu8.com/highlight/detail?id=2591598949","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591598949?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:00","pubTimestamp":1765886452,"startTime":"0","endTime":"0","summary":"EyePoint Inc. has granted non-statutory stock options to nine new employees as inducement awards outside its 2023 Long-Term Incentive Plan. The options cover up to 137,000 shares of common stock at an exercise price of $16.40 per share, the closing price on December 15, 2025. Each option has a ten-year term and vests over four years, with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal monthly installments over the following three years, contingent on continued employment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EyePoint Inc. published the original content used to generate this news brief via GlobeNewswire  on December 16, 2025, and is solely responsible for the information contained the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL1txfwH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU0320765992.SGD","SG9999014021.USD","SG9999014039.USD","BK4112","LU0109394709.USD","LU0314104364.USD","IE00BKPKM429.USD","EYPT","IE00BGHQF748.EUR","SG9999014013.SGD","IE00B3QW5Z07.USD","LU0889565916.HKD","IE00B64PRP62.GBP","LU2095319765.USD","BK4588","SG9999014005.SGD","NDAQ","BK4007","BK4585","LU2210149790.SGD"],"gpt_icon":0},{"id":"2591989432","title":"EyePoint Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2591989432","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591989432?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:00","pubTimestamp":1765886401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA3VSZVZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LU0889565916.HKD","LU0320765992.SGD","BK4588","EYPT","LU0109394709.USD","BK4585"],"gpt_icon":0},{"id":"2591686709","title":"After Leaping 38% EyePoint, Inc. (NASDAQ:EYPT) Shares Are Not Flying Under The Radar","url":"https://stock-news.laohu8.com/highlight/detail?id=2591686709","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591686709?lang=en_us&edition=fundamental","pubTime":"2025-12-13 02:17","pubTimestamp":1765563443,"startTime":"0","endTime":"0","summary":"EyePoint, Inc. ( NASDAQ:EYPT ) shareholders would be excited to see that the share price has had a great month, posting...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eypt/eyepoint/news/after-leaping-38-eyepoint-inc-nasdaqeypt-shares-are-not-flyi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eypt/eyepoint/news/after-leaping-38-eyepoint-inc-nasdaqeypt-shares-are-not-flyi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0109394709.USD","USJW.SI","LU0889565916.HKD","PSQ","MNQmain","BK4588",".IXIC","QLD","EYPT","SQQQ","TSYW.SI","LU0320765992.SGD","NQmain","NVIW.SI","QID","USAW.SI","BK4007","TQQQ","BK4585"],"gpt_icon":1},{"id":"2590365988","title":"Cormorant Asset Management Reports Sale of EyePoint Pharmaceuticals Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590365988","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590365988?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:04","pubTimestamp":1765227870,"startTime":"0","endTime":"0","summary":"Cormorant Asset Management, LP has reported a disposal of common shares of EyePoint Pharmaceuticals Inc. , according to a recent SEC filing. The form was filed by Cormorant Asset Management, LP and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EyePoint Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 08, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDLccFWq3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cormorant Asset Management Reports Sale of EyePoint Pharmaceuticals Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4007","LU0320765992.SGD","BK4588","EYPT","BK4585","LU0889565916.HKD"],"gpt_icon":0},{"id":"2589687351","title":"EyePoint Pharmaceuticals Inc - Changes Name to EyePoint, Inc. - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2589687351","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589687351?lang=en_us&edition=fundamental","pubTime":"2025-12-08 22:51","pubTimestamp":1765205476,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nFWN3XE0Y8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4588","LU0320765992.SGD","LU0889565916.HKD","EYPT","BK4585","LU0109394709.USD"],"gpt_icon":0},{"id":"2589351689","title":"EyePoint Pharmaceuticals Amends Bylaws to Reflect Name Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2589351689","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589351689?lang=en_us&edition=fundamental","pubTime":"2025-12-08 22:50","pubTimestamp":1765205424,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals Inc. has amended its bylaws to reflect a corporate name change to EyePoint, Inc., effective December 8, 2025. No other changes were made to the bylaws. The company's common stock continues to trade under the ticker symbol \"EYPT\" and the CUSIP number remains unchanged.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EyePoint Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 08, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL9Hjtv8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","EYPT","LU0320765992.SGD","BK4585","LU0889565916.HKD","BK4007","BK4588"],"gpt_icon":0},{"id":"2589703817","title":"EyePoint Pharmaceuticals Director Nancy Lurker Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2589703817","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589703817?lang=en_us&edition=fundamental","pubTime":"2025-12-06 05:07","pubTimestamp":1764968851,"startTime":"0","endTime":"0","summary":"Nancy Lurker, Director at EyePoint Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EyePoint Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDLnBd33:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"EyePoint Pharmaceuticals Director Nancy Lurker Reports Disposal of Common Shares","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYPT","LU0889565916.HKD","LU0320765992.SGD","BK4007","BK4588","BK4585","LU0109394709.USD"],"gpt_icon":0},{"id":"2588038657","title":"Director Nancy Lurker Reports Sale of EyePoint Pharmaceuticals Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588038657","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588038657?lang=en_us&edition=fundamental","pubTime":"2025-12-02 05:10","pubTimestamp":1764623434,"startTime":"0","endTime":"0","summary":"Nancy Lurker, Director at EyePoint Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EyePoint Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL9FRlcb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director Nancy Lurker Reports Sale of EyePoint Pharmaceuticals Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4588","LU0889565916.HKD","LU0109394709.USD","EYPT","BK4585","LU0320765992.SGD"],"gpt_icon":0},{"id":"2587473754","title":"EyePoint Pharmaceuticals (EYPT) Is Up 8.4% After Positive Phase 3 Safety Review for DURAVYU","url":"https://stock-news.laohu8.com/highlight/detail?id=2587473754","media":"Simply Wall St.","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587473754?lang=en_us&edition=fundamental","pubTime":"2025-11-29 11:21","pubTimestamp":1764386464,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals recently announced that the independent Data Safety Monitoring Committee completed its second scheduled review of the pivotal Phase 3 trial for DURAVYU, an investigational sustained-release therapy for wet age-related macular degeneration (wet AMD).\nThis review highlights DURAVYU's potential to offer a differentiated, long-acting treatment option for both wet AMD and diabetic macular edema (DME), addressing therapeutic needs in these growing patient...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eypt/eyepoint-pharmaceuticals/news/eyepoint-pharmaceuticals-eypt-is-up-84-after-positive-phase","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eypt/eyepoint-pharmaceuticals/news/eyepoint-pharmaceuticals-eypt-is-up-84-after-positive-phase","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE0004445239.USD","LU1989764664.SGD","LU0823421416.USD","LU1303367103.USD","IE00B5949003.HKD","LU2250418816.HKD","BK4534","LU0979878070.USD","LU1064131342.USD","BK4141","LU1242518931.SGD","BK4605","BK4512","LU2089985449.USD","LU2931357623.SGD","LU0109394709.USD","LU0889565833.HKD","BK4575","IE0009356076.USD","LU1242518857.USD","LU1861558580.USD","LU0823434583.USD","DME.AU","LU0274383776.USD","LU0823421333.USD","LU2458330169.SGD","LU2054465674.USD","BK4554","LU0081259029.USD","LU0320765992.SGD","LU0127658192.USD","LU1316542783.SGD","LU2458330243.SGD","LU2264538146.SGD","LU1861559042.SGD","LU0642271901.SGD","LU2355687059.USD","BK4614","LU0719512351.SGD","LU1951200564.SGD","EYPT","LU0390134368.USD","BK4529","IE00BMPRXN33.USD","LU1988902786.USD","BK4588","BK4573","BK7095","GFS"],"gpt_icon":1},{"id":"2584946041","title":"EyePoint Pharmaceuticals Receives Positive Phase 3 Trial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2584946041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584946041?lang=en_us&edition=fundamental","pubTime":"2025-11-19 20:28","pubTimestamp":1763555324,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals ( ($EYPT) ) has provided an announcement. On November 19, 2025, EyePoint Pharmaceuticals announced a positive recommendati...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eyepoint-pharmaceuticals-receives-positive-phase-3-trial-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eyepoint-pharmaceuticals-receives-positive-phase-3-trial-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EYPT","LU0889565916.HKD","LU0320765992.SGD","BK4007","BK4588","BK4585","LU0109394709.USD"],"gpt_icon":0},{"id":"2584450789","title":"BRIEF-EyePoint announces positive recommendation by Data Safety Monitoring Committee for phase 3 trials for Duravyu","url":"https://stock-news.laohu8.com/highlight/detail?id=2584450789","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584450789?lang=en_us&edition=fundamental","pubTime":"2025-11-19 20:17","pubTimestamp":1763554630,"startTime":"0","endTime":"0","summary":"BRIEF-EyePoint announces positive recommendation by Data Safety Monitoring Committee for phase 3 trials for DuravyuNov 19 (Reuters) - EyePoint Pharmaceuticals Inc EYPT.O:EYEPOINT ANNOUNCES POSITIVE RE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA491CPL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0109394709.USD","BK4588","LU0889565916.HKD","BK4585","EYPT","LU0320765992.SGD"],"gpt_icon":0},{"id":"2584494599","title":"EyePoint Pharmaceuticals Inc - Topline Data for Lugano Expected Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2584494599","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584494599?lang=en_us&edition=fundamental","pubTime":"2025-11-19 20:00","pubTimestamp":1763553603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA491CPL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","EYPT","BK4585","BK4007"],"gpt_icon":0},{"id":"2584945190","title":"EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration","url":"https://stock-news.laohu8.com/highlight/detail?id=2584945190","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584945190?lang=en_us&edition=fundamental","pubTime":"2025-11-19 20:00","pubTimestamp":1763553600,"startTime":"0","endTime":"0","summary":"– No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show no safety signals, consistent with previous clinical trials for DURAVYU – – On track ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/19/3190786/0/en/EyePoint-Announces-Positive-Recommendation-from-Independent-Data-Safety-Monitoring-Committee-for-Pivotal-Phase-3-Trials-for-DURAVYU-in-Wet-Age-Related-Macular-Degeneration.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1951198990.SGD","LU1989764664.SGD","LU0056508442.USD","LU0127658192.USD","LU1803068979.SGD","LU0979878070.USD","BK4529","EYPT","LU0823434583.USD","LU0390134368.USD","LU2250418816.HKD","LU1923623000.USD","DSMC","LU1861558580.USD","LU0109392836.USD","BK4534","LU1852331112.SGD","LU2458330243.SGD","LU2098885051.SGD","LU0823421416.USD","IE00BMPRXR70.SGD","LU1316542783.SGD","BK4532","BK4588","BK4512","LU1951200564.SGD","LU0198837287.USD","BK4554","IE0009356076.USD","BK4141","BK4573","LU2931357623.SGD","BK4575","LU2054465674.USD","GFS","BK4605","IE0004445239.USD","BK4585","LU0719512351.SGD","LU0823421333.USD","BK4566","LU1880398554.USD","LU2458330169.SGD","LU0081259029.USD","LU1303367103.USD","LU0642271901.SGD","LU1064131342.USD","BK4007","LU0823434740.USD"],"gpt_icon":1},{"id":"2584604640","title":"A Look at EyePoint Pharmaceuticals’s (EYPT) Valuation Following Steep Revenue Drop and Wider Quarterly Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2584604640","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584604640?lang=en_us&edition=fundamental","pubTime":"2025-11-18 07:22","pubTimestamp":1763421759,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals (EYPT) just released third-quarter earnings, revealing that revenue fell sharply to $0.97 million from $10.5 million last year. Net loss nearly doubled during the same period.\nSee our latest analysis for EyePoint Pharmaceuticals.\nShares of EyePoint Pharmaceuticals have maintained solid momentum in 2024, with a year-to-date share price return of 44.2% and a 1-year total shareholder return of nearly 35%. While there was a dip in quarterly revenue, investors appear...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eypt/eyepoint-pharmaceuticals/news/a-look-at-eyepoint-pharmaceuticalss-eypt-valuation-following","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eypt/eyepoint-pharmaceuticals/news/a-look-at-eyepoint-pharmaceuticalss-eypt-valuation-following","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EYPT"],"gpt_icon":0},{"id":"2584628487","title":"EyePoint reports inducement grants under NASDAQ listing rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2584628487","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584628487?lang=en_us&edition=fundamental","pubTime":"2025-11-17 20:10","pubTimestamp":1763381454,"startTime":"0","endTime":"0","summary":"EyePoint (EYPT) Pharmaceuticals announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eyepoint-reports-inducement-grants-under-nasdaq-listing-rule-thefly-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eyepoint-reports-inducement-grants-under-nasdaq-listing-rule-thefly-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USJW.SI","NQmain","TSYW.SI","NVIW.SI","TQQQ","EYPT","LU0889565916.HKD","BK4588","PSQ","LU0320765992.SGD",".IXIC","SQQQ","BK4585","LU0109394709.USD","MNQmain","QLD","USAW.SI","QID","BK4007"],"gpt_icon":0},{"id":"2584886628","title":"EyePoint Pharmaceuticals Grants Stock Options to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2584886628","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584886628?lang=en_us&edition=fundamental","pubTime":"2025-11-17 20:04","pubTimestamp":1763381065,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals Inc. has granted non-statutory stock options to seven new employees as part of inducement awards. The company issued options to purchase a total of 31,000 shares of common stock at an exercise price of $11.58 per share, reflecting the closing price on November 14, 2025. Each option has a ten-year term and will vest over four years, with 25% vesting after one year and the remainder vesting in equal monthly installments over the following three years, contingent on continued employment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EyePoint Pharmaceuticals Inc. published the original content used to generate this news brief on November 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL5zR2CG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4588","BK4007","EYPT","LU0320765992.SGD","BK4585","LU0889565916.HKD"],"gpt_icon":0},{"id":"2584218694","title":"Promising Outlook for EyePoint Pharmaceuticals with Duravyu’s Potential Impact on Wet AMD Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2584218694","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584218694?lang=en_us&edition=fundamental","pubTime":"2025-11-17 08:15","pubTimestamp":1763338519,"startTime":"0","endTime":"0","summary":"Debanjana Chatterjee, an analyst from JonesTrading, maintained the Buy rating on EyePoint Pharmaceuticals. The associated price target remains the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-outlook-for-eyepoint-pharmaceuticals-with-duravyus-potential-impact-on-wet-amd-treatment-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-outlook-for-eyepoint-pharmaceuticals-with-duravyus-potential-impact-on-wet-amd-treatment-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0004445239.USD","LU0127658192.USD","BK4534","LU1852331112.SGD","LU0274383776.USD","LU1064131342.USD","LU0823421416.USD","LU1951198990.SGD","BK4512","LU1861559042.SGD","EYPT","LU0390134368.USD","BK4529","BK4141","IE00BMPRXR70.SGD","IE00B5949003.HKD","LU2089985449.USD","LU0082616367.USD","BK4532","LU0823434583.USD","LU2458330243.SGD","BK4585","BK4573","IE0009356076.USD","LU0056508442.USD","LU0719512351.SGD","LU1316542783.SGD","BK4543","LU0823434740.USD","LU2931357623.SGD","LU2360106780.USD","LU2264538146.SGD","BK4588","LU1988902786.USD","BK4554","LU0320765992.SGD","LU2458330169.SGD","LU0081259029.USD","LU0979878070.USD","LU0198837287.USD","LU1242518931.SGD","LU2054465674.USD","BK4566","LU1923623000.USD","BK4614","LU0109394709.USD","LU0642271901.SGD","GFS","BK4612"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":114,"code":"91000000","status":"200"}]}}